Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Sep 20, 2019

The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Sep 18, 2019

Provention Bio Announces Pricing of $40 Million Public Offering of Common Stock
Sep 18, 2019

Provention Bio Announces Proposed Public Offering of Common Stock
Sep 18, 2019

Educational campaign helps teens and their caregivers tackle the everyday challenges of living with moderate-to-severe atopic dermatitis

Understand AD program brings together a team of experts to help a teen with severe atopic dermatitis (AD) and his parents navigate the disease
Sep 16, 2019

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.